title: Mylotarg is not a "magic bullet".
authors.forename: Ritsuro
authors.initials: R
authors.lastname: Suzuki
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Naoko
authors.initials: N
authors.lastname: Murashige
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kami
mesh_terms: D000617:Aminoglycosides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000918:Antibody Specificity; D000079982:Gemtuzumab; D006801:Humans; D020014:K562 Cells; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D012008:Recurrence
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab